• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种主要形式的炎症性肠病的细胞和分子机制。

Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.

机构信息

Department of Internal Medicine, Peterfy Hospital, Budapest, Hungary.

出版信息

Pathol Oncol Res. 2011 Sep;17(3):463-72. doi: 10.1007/s12253-011-9397-4. Epub 2011 Jun 17.

DOI:10.1007/s12253-011-9397-4
PMID:21681604
Abstract

The factors involved in the pathogenesis of Crohn's disease and ulcerative colitis, the two major types of inflammatory bowel disease (IBD) are summarized. Intestinal antigens composed of bacterial flora along with antigen presentation and impaired mucosal barrier have an important role in the initiation of IBD. The bacterial community may be modified by the use of antibiotics and probiotics. The dentritic cells recognize the antigens by cell surface Toll like receptor and the cytoplasmic CARD/NOD system. The balance between Th1/Th2/Th17 cell populations being the source of a variety of cytokines regulates the inflammatory mechanisms and the clearance of microbes. The intracellular killing and digestion, including autophagy, are important in the protection against microbes and their toxins. The homing process determines the location and distribution of the immune cells along the gut. All these players are potential targets of pharmacological manipulation of disease status.

摘要

总结了导致克罗恩病和溃疡性结肠炎(两种主要的炎症性肠病,IBD)发病的相关因素。肠道抗原由肠道菌群以及抗原呈递和受损的黏膜屏障组成,在 IBD 的发生中起重要作用。抗生素和益生菌的使用可能会改变肠道菌群。树突状细胞通过细胞表面 Toll 样受体和细胞质 CARD/NOD 系统识别抗原。Th1/Th2/Th17 细胞群之间的平衡是各种细胞因子的来源,调节炎症机制和微生物的清除。包括自噬在内的细胞内杀伤和消化在防止微生物及其毒素方面非常重要。归巢过程决定了免疫细胞在肠道中的位置和分布。所有这些参与者都是疾病状态药物治疗的潜在靶点。

相似文献

1
Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.两种主要形式的炎症性肠病的细胞和分子机制。
Pathol Oncol Res. 2011 Sep;17(3):463-72. doi: 10.1007/s12253-011-9397-4. Epub 2011 Jun 17.
2
Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II).炎症性肠病:肠道相关淋巴组织及肠道菌群功能障碍(二)
Surgeon. 2003 Jun;1(3):125-36. doi: 10.1016/s1479-666x(03)80091-4.
3
Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病的病因及发病机制的当前概念
Gastroenterol Clin North Am. 1995 Sep;24(3):475-507.
4
Regulatory cytokines in inflammatory bowel disease.
Aliment Pharmacol Ther. 1996;10 Suppl 2:75-9; discussion 80. doi: 10.1046/j.1365-2036.1996.22164024.x.
5
Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.肠黏膜通透性受损与炎症性肠病和黏膜愈合患者持续的肠道症状有关。
Gastroenterology. 2017 Sep;153(3):723-731.e1. doi: 10.1053/j.gastro.2017.05.056. Epub 2017 Jun 8.
6
The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.炎症性肠病中的细菌菌群:发病机制的当前见解以及抗生素和益生菌的影响
Scand J Gastroenterol Suppl. 2001(234):29-40. doi: 10.1080/003655201753265082.
7
[Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy)].[克罗恩病和溃疡性结肠炎的环境风险因素(不包括烟草和阑尾切除术)]
Gastroenterol Clin Biol. 2006 Jun-Jul;30(6-7):859-67. doi: 10.1016/s0399-8320(06)73333-4.
8
Cytokines in inflammatory bowel diseases - Update 2020.炎症性肠病中的细胞因子 - 2020 更新。
Pharmacol Res. 2020 Aug;158:104835. doi: 10.1016/j.phrs.2020.104835. Epub 2020 May 13.
9
[Chronic inflammatory bowel diseases. Pathophysiology and drug therapy].
Radiologe. 1998 Jan;38(1):3-7. doi: 10.1007/s001170050316.
10
Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.作为炎症性肠病疾病活动标志物的N-甲基组胺的尿排泄量
Am J Gastroenterol. 2002 Dec;97(12):3071-7. doi: 10.1111/j.1572-0241.2002.07028.x.

引用本文的文献

1
New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease.关于促消退脂质介质在炎症性肠病中作用的新转化和实验见解。
World J Exp Med. 2022 Jan 20;12(1):1-15. doi: 10.5493/wjem.v12.i1.1.
2
Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways.双歧杆菌通过 NF-κB 和 p38MAPK 通路在 TNF-α 诱导的 Caco-2 细胞炎症反应中发挥保护作用。
Mol Cell Biochem. 2020 Jan;464(1-2):83-91. doi: 10.1007/s11010-019-03651-3. Epub 2019 Nov 18.
3
Patterns of mucosal inflammation in pediatric inflammatory bowel disease: striking overexpression of IL-17A in children with ulcerative colitis.

本文引用的文献

1
Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.血清脂多糖结合蛋白和可溶性 CD14 是克罗恩病患者疾病活动的标志物。
Inflamm Bowel Dis. 2011 Mar;17(3):767-77. doi: 10.1002/ibd.21402. Epub 2010 Sep 23.
2
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.上皮细胞衍生的白介素 33 及其受体 ST2 在溃疡性结肠炎和实验性 Th1/Th2 驱动的肠炎中失调。
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):8017-22. doi: 10.1073/pnas.0912678107. Epub 2010 Apr 12.
3
Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease.
儿童炎症性肠病的黏膜炎症模式:溃疡性结肠炎患儿中 IL-17A 的显著过表达。
Pediatr Res. 2020 Apr;87(5):839-846. doi: 10.1038/s41390-019-0486-5. Epub 2019 Jul 1.
4
Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics.炎症性肠病:生物制剂分子靶点的最新进展
Gut Liver. 2017 Jul 15;11(4):455-463. doi: 10.5009/gnl16308.
5
The oncoprotein and transcriptional regulator Bcl-3 governs plasticity and pathogenicity of autoimmune T cells.癌蛋白和转录调节因子Bcl-3调控自身免疫性T细胞的可塑性和致病性。
Immunity. 2014 Oct 16;41(4):555-66. doi: 10.1016/j.immuni.2014.09.017.
6
Excretory/secretory products from Trichinella spiralis adult worms ameliorate DSS-induced colitis in mice.旋毛虫成虫的排泄/分泌产物可改善右旋葡聚糖硫酸钠(DSS)诱导的小鼠结肠炎。
PLoS One. 2014 May 2;9(5):e96454. doi: 10.1371/journal.pone.0096454. eCollection 2014.
7
Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.克罗恩病中双肽基二肽感应通路:从 NOD2 开始
Cell Mol Life Sci. 2013 Sep;70(18):3391-404. doi: 10.1007/s00018-012-1246-4. Epub 2012 Dec 29.
8
Angioedema associated with Crohn's disease: response to biologics.与克罗恩病相关的血管性水肿:对生物制剂的反应。
World J Gastroenterol. 2012 Sep 14;18(34):4787-90. doi: 10.3748/wjg.v18.i34.4787.
基质金属蛋白酶及其抑制剂在小儿炎症性肠病相关结肠炎症中的表达谱
Scand J Gastroenterol. 2010 Aug;45(7-8):862-71. doi: 10.3109/00365520903583863.
4
Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.IL-23 与 Th17 细胞因子的协同作用:炎症性肠病的新认识。
Neurochem Res. 2010 Jun;35(6):940-6. doi: 10.1007/s11064-009-0091-9. Epub 2009 Nov 14.
5
Defensins and inflammation: the role of defensins in inflammatory bowel disease.防御素与炎症:防御素在炎症性肠病中的作用
J Gastroenterol Hepatol. 2009 Feb;24(2):202-8. doi: 10.1111/j.1440-1746.2008.05772.x.
6
Role of mucosal dendritic cells in inflammatory bowel disease.黏膜树突状细胞在炎症性肠病中的作用。
World J Gastroenterol. 2008 Sep 7;14(33):5138-48. doi: 10.3748/wjg.14.5138.
7
The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients.3'非翻译区NFKBIA变异与匈牙利炎症性肠病患者的广泛性结肠炎相关。
Dig Dis Sci. 2009 Feb;54(2):351-9. doi: 10.1007/s10620-008-0351-6. Epub 2008 Aug 21.
8
ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients.自噬相关蛋白16样蛋白1(ATG16L1)基因和白细胞介素23受体(IL23R)基因与匈牙利克罗恩病患者的疾病易感性相关。
Dig Liver Dis. 2008 Nov;40(11):867-73. doi: 10.1016/j.dld.2008.03.022. Epub 2008 May 22.
9
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.转化生长因子β诱导的Foxp3通过拮抗RORγt功能抑制辅助性T细胞17分化。
Nature. 2008 May 8;453(7192):236-40. doi: 10.1038/nature06878. Epub 2008 Mar 26.
10
Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.炎症性肠病患者活检样本中Toll样受体2(TLR2)、TLR4和CD14的表达:溃疡性结肠炎患者回肠末端TLR2表达上调。
J Histochem Cytochem. 2008 Mar;56(3):267-74. doi: 10.1369/jhc.7A7303.2007. Epub 2007 Nov 26.